» Articles » PMID: 34976444

New Radiomic Markers of Pulmonary Vein Morphology Associated With Post-Ablation Recurrence of Atrial Fibrillation

Abstract

To identify radiomic and clinical features associated with post-ablation recurrence of AF, given that cardiac morphologic changes are associated with persistent atrial fibrillation (AF), and initiating triggers of AF often arise from the pulmonary veins which are targeted in ablation. Subjects with pre-ablation contrast CT scans prior to first-time catheter ablation for AF between 2014-2016 were retrospectively identified. A training dataset (D) was constructed from left atrial and pulmonary vein morphometric features extracted from equal numbers of consecutively included subjects with and without AF recurrence determined at 1 year. The top-performing combination of feature selection and classifier methods based on C-statistic was evaluated on a validation dataset (D), composed of subjects retrospectively identified between 2005-2010. Clinical models ([Formula: see text]) were similarly evaluated and compared to radiomic ([Formula: see text]) and radiomic-clinical models ([Formula: see text]), each independently validated on D. Of 150 subjects in D, 108 received radiofrequency ablation and 42 received cryoballoon. Radiomic features of recurrence included greater right carina angle, reduced anterior-posterior atrial diameter, greater atrial volume normalized to height, and steeper right inferior pulmonary vein angle. Clinical features predicting recurrence included older age, greater BMI, hypertension, and warfarin use; apixaban use was associated with reduced recurrence. AF recurrence was predicted with radio-frequency ablation models on D subjects with C-statistics of 0.68, 0.63, and 0.70 for radiomic, clinical, and combined feature models, though these were not prognostic in patients treated with cryoballoon. Pulmonary vein morphology associated with increased likelihood of AF recurrence within 1 year of catheter ablation was identified on cardiac CT. Radiomic and clinical features-based predictive models may assist in identifying atrial fibrillation ablation candidates with greatest likelihood of successful outcome.

Citing Articles

Artificial Intelligence-Based Feature Analysis of Pulmonary Vein Morphology on Computed Tomography Scans and Risk of Atrial Fibrillation Recurrence After Catheter Ablation: A Multi-Site Study.

Asaeikheybari G, El-Harasis M, Gupta A, Shoemaker M, Barnard J, Hunter J Circ Arrhythm Electrophysiol. 2024; 17(12):e012679.

PMID: 39624901 PMC: 11662226. DOI: 10.1161/CIRCEP.123.012679.


Beyond Clinical Factors: Harnessing Artificial Intelligence and Multimodal Cardiac Imaging to Predict Atrial Fibrillation Recurrence Post-Catheter Ablation.

Truong E, Lyu Y, Ihdayhid A, Lan N, Dwivedi G J Cardiovasc Dev Dis. 2024; 11(9).

PMID: 39330349 PMC: 11432286. DOI: 10.3390/jcdd11090291.


Value of Imaging in the Non-Invasive Prediction of Recurrence after Catheter Ablation in Patients with Atrial Fibrillation: An Up-to-Date Review.

Jing M, Li D, Xi H, Zhang Y, Zhou J Rev Cardiovasc Med. 2024; 24(8):241.

PMID: 39076720 PMC: 11266785. DOI: 10.31083/j.rcm2408241.


Predictive Value of Machine Learning for Recurrence of Atrial Fibrillation after Catheter Ablation: A Systematic Review and Meta-Analysis.

Fan X, Li Y, He Q, Wang M, Lan X, Zhang K Rev Cardiovasc Med. 2024; 24(11):315.

PMID: 39076446 PMC: 11272879. DOI: 10.31083/j.rcm2411315.


Left Atrial Volume Index Predicts Atrial Fibrillation Recurrence after Catheter Ablation Only in Obese Patients-Brief Report.

Naji F, Alatic J, Balevski I, Suran D Diagnostics (Basel). 2024; 14(14).

PMID: 39061707 PMC: 11275257. DOI: 10.3390/diagnostics14141570.


References
1.
Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo C . Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J. 2010; 31(11):1344-56. PMC: 2878965. DOI: 10.1093/eurheartj/ehq041. View

2.
Calkins H, Reynolds M, Spector P, Sondhi M, Xu Y, Martin A . Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009; 2(4):349-61. DOI: 10.1161/CIRCEP.108.824789. View

3.
Verma A, Jiang C, Betts T, Chen J, Deisenhofer I, Mantovan R . Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015; 372(19):1812-22. DOI: 10.1056/NEJMoa1408288. View

4.
Hussein A, Lindsay B, Madden R, Martin D, Saliba W, Tarakji K . New Model of Automated Patient-Reported Outcomes Applied in Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019; 12(3):e006986. DOI: 10.1161/CIRCEP.118.006986. View

5.
Mont L, Tamborero D, Elosua R, Molina I, Coll-Vinent B, Sitges M . Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace. 2008; 10(1):15-20. DOI: 10.1093/europace/eum263. View